Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.

Literature DB >> 16296876

Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.

Abstract

Quetiapine (Seroquel), an atypical antipsychotic with established efficacy in the treatment of schizophrenia, shows efficacy in the treatment of acute mania and depression associated with bipolar disorder.Quetiapine, either as monotherapy or in combination with lithium or divalproex sodium (valproate semisodium), is generally well tolerated and effective in reducing manic symptoms in adult and adolescent patients with acute bipolar mania, and is approved for use in adults for this indication. As monotherapy, the drug is also effective in reducing depressive symptoms in patients with bipolar depression. It is associated with a low incidence of extrapyramidal symptom (EPS)-related adverse events and low EPS ratings in bipolar disorder. Quetiapine thus shows potential in the treatment of bipolar depression, and represents a useful agent for the treatment of acute bipolar mania.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2005 PMID： 16296876 DOI： 10.2165/00003495-200565170-00008

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

35 in total

1. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

Authors: B J McConville; L A Arvanitis; P T Thyrum; C Yeh; L A Wilkinson; R O Chaney; K D Foster; M T Sorter; L M Friedman; K L Brown; J E Heubi
Journal: J Clin Psychiatry Date: 2000-04 Impact factor: 4.384

2. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Authors: Steven G Potkin; Per T Thyrum; Gustavo Alva; Rimal Bera; Chiao Yeh; Lisa A Arvanitis
Journal: J Clin Psychopharmacol Date: 2002-04 Impact factor: 3.153

3. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.

Authors: Y W Wong; C Yeh; P T Thyrum
Journal: J Clin Psychopharmacol Date: 2001-02 Impact factor: 3.153

Review 4. Efficacy of atypical antipsychotics in bipolar disorder.

Authors: Michael Berk; Seetal Dodd
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 5. Valproate for acute mood episodes in bipolar disorder.

Authors: K Macritchie; J R Geddes; J Scott; D Haslam; M de Lima; G Goodwin
Journal: Cochrane Database Syst Rev Date: 2003

Review 6. A review of acute treatments for bipolar depression.

Authors: Peter H Silverstone; Trevor Silverstone
Journal: Int Clin Psychopharmacol Date: 2004-05 Impact factor: 1.659

7. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.

Authors: G Sachs; K N R Chengappa; T Suppes; J A Mullen; M Brecher; N A Devine; D E Sweitzer
Journal: Bipolar Disord Date: 2004-06 Impact factor: 6.744

8. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.

Authors: G M Goodwin
Journal: J Psychopharmacol Date: 2003-06 Impact factor: 4.153

9. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.

Authors: Steven G Potkin; Per T Thyrum; Rimal Bera; Daniel Carreon; Gustavo Alva; Amir H Kalali; Chiao Yeh
Journal: Clin Ther Date: 2002-11 Impact factor: 3.393

Review 10. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

Authors: Robert M Post; Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha M Suppes; Paul E Keck; Susan L McElroy; Ralph Kupka; Willem A Nolen; Heinz Grunze; Jorg Walden
Journal: Bipolar Disord Date: 2003-10 Impact factor: 6.744

7 in total

1. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.

Authors: Mazlum Copur; Baki Arpaci; Turkay Demir; Halis Narin
Journal: Clin Drug Investig Date: 2007 Impact factor: 2.859

Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.

1. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.

2. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

3. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.

Review 4. Efficacy of atypical antipsychotics in bipolar disorder.

Review 5. Valproate for acute mood episodes in bipolar disorder.

Review 6. A review of acute treatments for bipolar depression.

7. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.

8. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.

9. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.

Review 10. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).

1. Clinical effectiveness of quetiapine in children and adolescents with Tourette's syndrome : a retrospective case-note survey.

Review 2. The Black Book of Psychotropic Dosing and Monitoring.

Review 3. Co-occurring depressive symptoms in the older patient with schizophrenia.

Review 4. Quetiapine: a review of its use in the treatment of bipolar depression.

5. Investigation of the Pharmaceutical Care in One Elderly Parkinson's Disease Patient with Psychotic Symptoms.

6. New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine.

7. A review of quetiapine in combination with antidepressant therapy in patients with depression.